{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:34:40Z","timestamp":1792589680831,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"NIH Office of the Director","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jconrel.2021.01.023","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T20:10:51Z","timestamp":1611000651000},"page":"19-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["ImmunoPET-informed sequence for focused ultrasound-targeted mCD47 blockade controls glioma"],"prefix":"10.1016","volume":"331","author":[{"given":"Natasha D.","family":"Sheybani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria R.","family":"Breza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumen","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyenn S.","family":"McCauley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart S.","family":"Berr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Wilson","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiel D.","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2021.01.023_bb0005","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fsurg.2016.00011","article-title":"Immune evasion strategies of glioblastoma","volume":"3","author":"Razavi","year":"2016","journal-title":"Front. Surg."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.aaf2968","article-title":"Disrupting the CD47-SIRP\u03b1 anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors","volume":"9","author":"Gholamin","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0020","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1073\/pnas.1721434116","article-title":"Microglia are effector cells of CD47-SIRP\u03b1 antiphagocytic axis disruption against glioblastoma","volume":"116","author":"Hutter","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0025","article-title":"Anti-CD47 treatment stimulates phagocytosis of glioblastoma by M1 and M2 polarized macrophages and promotes M1 polarized macrophages in vivo","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2021.01.023_bb0030","doi-asserted-by":"crossref","first-page":"609","DOI":"10.21037\/tcr.2018.05.31","article-title":"Prognostic significance of CD47 in human malignancies: a systematic review and meta-analysis","volume":"7","author":"Zhao","year":"2018","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev-immunol-032713-120142","article-title":"The interaction between signal regulatory protein alpha (SIRP \u03b1) and CD47: structure, function, and therapeutic target","volume":"32","author":"Barclay","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0040","doi-asserted-by":"crossref","first-page":"6662","DOI":"10.1073\/pnas.1121623109","article-title":"The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors","volume":"109","author":"Willingham","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0045","doi-asserted-by":"crossref","first-page":"e1391973","DOI":"10.1080\/2162402X.2017.1391973","article-title":"Blocking the CD47-SIRP\u03b1 axis by delivery of anti-CD47 antibody induces antitumor effects in glioma and glioma stem cells","volume":"7","author":"Li","year":"2017","journal-title":"Oncoimmunology."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0050","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001375","article-title":"Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47","volume":"2","author":"Chao","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0055","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/s41467-020-15129-8","article-title":"Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity","volume":"11","author":"von Roemeling","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0060","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1517\/17425247.2013.808184","article-title":"Targeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: crossing the blood-brain barrier divide","volume":"10","author":"Chacko","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0065","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.3389\/fimmu.2017.01181","article-title":"Targeting malignant brain tumors with antibodies","volume":"8","author":"Razpotnik","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0070","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1023\/A:1022592913323","article-title":"Plasma and cerebrospinal fluid pharmacokinetics of intravenous temozolomide in non-human primates","volume":"61","author":"Patel","year":"2003","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0075","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1158\/0008-5472.CAN-08-2356","article-title":"A new model for prediction of drug distribution in tumor and normal tissues: pharmacokinetics of temozolomide in glioma patients","volume":"69","author":"Rosso","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2015.02.002","article-title":"Overcoming the blood\u2013brain tumor barrier for effective glioblastoma treatment","volume":"19","author":"van Tellingen","year":"2015","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0085","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jconrel.2015.08.059","article-title":"Drug and gene delivery across the blood-brain barrier with focused ultrasound","volume":"219","author":"Timbie","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.01.023_bb0090","doi-asserted-by":"crossref","first-page":"11719","DOI":"10.1073\/pnas.0604318103","article-title":"Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption","volume":"103","author":"Kinoshita","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0095","doi-asserted-by":"crossref","first-page":"E8717","DOI":"10.1073\/pnas.1807105115","article-title":"Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood-tumor barrier disruption","volume":"115","author":"Arvanitis","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0100","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1148\/radiol.2016152444","article-title":"Focused ultrasound enhances central nervous system delivery of bevacizumab for malignant glioma treatment","volume":"281","author":"Liu","year":"2016","journal-title":"Radiology."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0105","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jconrel.2012.09.007","article-title":"Ultrasound-mediated blood-brain\/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model","volume":"163","author":"Park","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.01.023_bb0110","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jconrel.2015.02.033","article-title":"Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study","volume":"204","author":"Aryal","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.01.023_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-04529-6","article-title":"Blood\u2013brain barrier opening in Alzheimer\u2019s disease using MR-guided focused ultrasound","volume":"9","author":"Lipsman","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0120","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1038\/s41467-019-12426-9","article-title":"First-in-human trial of blood-brain barrier opening in amyotrophic lateral sclerosis using MR-guided focused ultrasound","volume":"10","author":"Abrahao","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0125","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41598-018-36340-0","article-title":"Blood-brain barrier opening in primary brain tumors with non-invasive MR-guided focused ultrasound: a clinical safety and feasibility study","volume":"9","author":"Mainprize","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2017.03.017","article-title":"MR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound","author":"Timbie","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.01.023_bb0135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2016.10.011","article-title":"Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption","volume":"250","author":"Park","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.01.023_bb0140","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jconrel.2012.06.012","article-title":"The kinetics of blood brain barrier permeability and targeted doxorubicin delivery into brain induced by focused ultrasound","volume":"162","author":"Park","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.01.023_bb0145","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.bbrc.2005.12.112","article-title":"Targeted delivery of antibodies through the blood\u2013brain barrier by MRI-guided focused ultrasound","volume":"340","author":"Kinoshita","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0002175","article-title":"Ultrasound enhanced delivery of molecular imaging and therapeutic agents in Alzheimer\u2019s disease mouse models","volume":"3","author":"Raymond","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2021.01.023_bb0155","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1371\/journal.pone.0010549","article-title":"Antibodies targeted to the brain with image-guided focused ultrasound reduces amyloid-\u03b2 plaque load in the TgCRND8 mouse model of Alzheimer\u2019s disease","volume":"5","author":"Jord\u00e3o","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2021.01.023_bb0160","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.expneurol.2013.05.008","article-title":"Amyloid-\u03b2 plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound","volume":"248","author":"Jord\u00e3o","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0165","first-page":"1","article-title":"Combined effects of scanning ultrasound and a tau-specific single chain antibody in a tau transgenic mouse model","author":"Nisbet","year":"2017","journal-title":"Brain."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0170","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jconrel.2016.08.001","article-title":"Growth inhibition in a brain metastasis model by antibody delivery using focused ultrasound-mediated blood-brain barrier disruption","volume":"238","author":"Kobus","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.01.023_bb0175","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf6086","article-title":"Clinical trial of blood-brain barrier disruption by pulsed ultrasound","volume":"8","author":"Carpentier","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0180","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jconrel.2015.12.034","article-title":"Targeted gene transfer to the brain via the delivery of brain-penetrating DNA nanoparticles with focused ultrasound","volume":"223","author":"Mead","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.01.023_bb0185","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay1344","article-title":"Augmentation of brain tumor interstitial flow via focused ultrasound promotes brain-penetrating nanoparticle dispersion and transfection","volume":"6","author":"Curley","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0190","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jconrel.2013.04.007","article-title":"Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model","volume":"169","author":"Aryal","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.01.023_bb0195","article-title":"Novel focused ultrasound gene therapy approach non-invasively restores dopaminergic neuron function in a rat Parkinson\u2019s disease model","author":"Mead, B.P.","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ultrasmedbio.2018.06.005","article-title":"Acoustic transmission factor through the rat skull as a function of body mass, frequency and position","author":"Gerstenmayer","year":"2018","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0205","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ultrasmedbio.2006.07.018","article-title":"Noninvasive, transcranial and localized opening of the blood-brain barrier using focused ultrasound in mice","volume":"33","author":"Choi","year":"2007","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0210","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1158\/0008-5472.CAN-10-4482","article-title":"Mild elevation of body temperature reduces tumor interstitial fluid pressure and hypoxia and enhances efficacy of radiotherapy in murine tumor models","volume":"71","author":"Sen","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0215","doi-asserted-by":"crossref","first-page":"6775","DOI":"10.1088\/0031-9155\/59\/22\/6775","article-title":"Modulation of the interstitial fluid pressure by high intensity focused ultrasound as a way to alter local fluid and solute movement: insights from a mathematical model","volume":"59","author":"Sassaroli","year":"2014","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0220","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3389\/fphar.2019.00716","article-title":"Effect of ultrasound combined with microbubble therapy on interstitial fluid pressure and VX2 tumor structure in rabbit","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0225","article-title":"Noninvasive ultrasonic glymphatic induction enhances intrathecal drug delivery","author":"Aryal","year":"2020","journal-title":"BioRxiv."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0230","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jconrel.2014.07.051","article-title":"Analysis of focused ultrasound-induced blood\u2013brain barrier permeability in a mouse model of Alzheimer\u2019s disease using two-photon microscopy","volume":"192","author":"Burgess","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.01.023_bb0235","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jconrel.2013.08.029","article-title":"Drug delivery to the brain by focused ultrasound induced blood-brain barrier disruption: quantitative evaluation of enhanced permeability of cerebral vasculature using two-photon microscopy","volume":"172","author":"Nhan","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.01.023_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166061","article-title":"Effects on P-glycoprotein expression after blood-brain barrier disruption using focused ultrasound and microbubbles","volume":"12","author":"Aryal","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2021.01.023_bb0245","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.ultrasmedbio.2007.12.015","article-title":"Effect of focused ultrasound applied with an ultrasound contrast agent on the tight Junctional integrity of the brain microvascular endothelium","volume":"34","author":"Sheikov","year":"2008","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0250","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.coi.2012.01.010","article-title":"The CD47\u2013SIRP\u03b1 pathway in cancer immune evasion and potential therapeutic implications","volume":"24","author":"Chao","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0255","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pharmthera.2017.07.005","article-title":"Toxicity profiles of immunotherapy","volume":"181","author":"Cousin","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0260","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1038\/s41467-020-17704-5","article-title":"Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types","volume":"11","author":"Khalsa","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0265","doi-asserted-by":"crossref","DOI":"10.7863\/ultra.16.02005","article-title":"Blood-brain barrier closure time after controlled ultrasound-induced opening is independent of opening volume","author":"O\u2019Reilly","year":"2017","journal-title":"J. Ultrasound Med."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0270","doi-asserted-by":"crossref","first-page":"22406","DOI":"10.18632\/oncotarget.9899","article-title":"CD47 deficiency in tumor stroma promotes tumor progression by enhancing angiogenesis","volume":"8","author":"Gao","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0275","doi-asserted-by":"crossref","first-page":"38923","DOI":"10.1074\/jbc.M110.172304","article-title":"Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47","volume":"285","author":"Kaur","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0280","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.addr.2014.01.008","article-title":"Ultrasound-mediated blood\u2013brain barrier disruption for targeted drug delivery in the central nervous system","volume":"72","author":"Aryal","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2020.05.020","article-title":"Focused ultrasound for opening blood-brain barrier and drug delivery monitored with positron emission tomography","author":"Arif","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.01.023_bb0290","doi-asserted-by":"crossref","first-page":"9180","DOI":"10.1073\/pnas.2002571117","article-title":"Noninvasive hippocampal blood-brain barrier opening in Alzheimer\u2019s disease with focused ultrasound","volume":"117","author":"Rezai","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0295","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fimmu.2020.00018","article-title":"Advances in anti-tumor treatments targeting the CD47\/SIRP\u03b1 Axis","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2021.01.023_bb0300","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jconrel.2012.07.005","article-title":"Markedly enhanced skeletal muscle transfection achieved by the ultrasound-targeted delivery of non-viral gene nanocarriers with microbubbles","volume":"162","author":"Burke","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.01.023_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2310\/7290.2013.00069","article-title":"Imaging of CD47 expression in xenograft and allograft tumor models","volume":"12","author":"Zheleznyak","year":"2013","journal-title":"Mol. Imaging"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921000328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921000328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:51:58Z","timestamp":1759161118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365921000328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":61,"alternative-id":["S0168365921000328"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.01.023","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.07.27.223206","asserted-by":"object"}]},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ImmunoPET-informed sequence for focused ultrasound-targeted mCD47 blockade controls glioma","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}